Background: Inflammation is a cardinal mechanism of diabetic kidney disease (DKD). Interleukin-6 (IL6) is a reliable indicator that plays a role in the progression of DKD. Monocyte-to-lymphocyte ratio (MLR) is also implicated in this inflammatory process. The progression of DKD is associated with increased carotid intima-media thickness (CIMT), which is an independent predictor of atherosclerosis. Aim: The role of IL6 and MLR ratio influencing the progression of DKD was assessed using the urinary albumin creatinine ratio (UACR) and glomerular filtration rate (GFR). Moreover, their contribution to increasing CIMT in DKD was assessed. Methods: An observational prospective study was conducted on ninety diabetic patients presented to the Internal Medicine Clinic at Kasr AlAiny. The subjects were classified into three groups, thirty patients for each, according to UACR: with normoalbuminuria, microalbuminuria, and macroalbuminuria. A history and clinical assessment, CBC, MLR, HbA1c, lipid profile, IL6, creatinine, and eGFR were carried out. Furthermore, CIMT was measured using Doppler ultrasound. Results: The results showed that IL6 and MLR were significantly higher in the macroalbuminuria group compared to the other two groups with p < 0.001, suggesting that their higher level could predict the progression of DKD. According to the ROC curve, the cutoff values of MLR and IL6 were 0.3425 and 7 pg/ml, respectively. Moreover, CIMT increased significantly in micro and macroalbuminuric patients with p > 0.001. IL6 and MLR were positively correlated with CIMT in micro and macroalbuminuric patients. Conclusion: Both MLR and IL-6, as simple biomarkers associated with increased CIMT, play an important role in predicting the nephropathy of DKD patients.
22 September 2026 in The Egyptian Journal of Internal Medicine
Background: Endothelial dysfunction plays a central role in the pathophysiology of diabetic kidney disease (DKD), leading to systemic vascular complications. Neuregulin 4 (Nrg4) has emerged as a novel marker with potential vascular protective properties, and its dysregulated expression may lead to vascular damage. Aim: Assess the correlation between Nrg4, flow-mediated dilatation (FMD%), and parameters of cerebral hemodynamics in type 2 DKD patients to evaluate endothelial dysfunction. Methods: A cross-sectional study included 120 participants, comprising 40 proteinuric type 2 diabetic patients, 40 nonproteinuric patients, and 40 controls. CBC, HbA1c, lipid profile, serum creatinine, albumin-to-creatinine ratio (ACR), and Nrg4 were measured. FMD, pulsatility index (PI), and breath-holding index (BHI) of the middle cerebral artery were assessed. Results: Proteinuric diabetics showed significantly lower Nrg4 and FMD (1.13 ± 0.41 ng/mL; 6.08 ± 1.78%) compared with nonproteinuric (3.07 ± 0.80 ng/mL; 11.23 ± 1.68%) and controls (10.05 ± 2.44 ng/mL; 16.13 ± 0.97%) ( p < 0.001). The proteinuric group showed significantly higher baseline PI and lower BHI (0.93 ± 0.12 and 0.30 ± 0.07) compared with the nonproteinuric group (0.67 ± 0.06 and 0.52 ± 0.05) and controls (0.55 ± 0.03 and 0.90 ± 0.13), respectively ( p < 0.001). Nrg4 showed positive correlations with FMD ( r = 0.971) and BHI ( r = 0.955), with p < 0.001. Nrg4 correlates negatively with PI ( r = -0.917, p < 0.001). Conclusion: Reduced Nrg4 levels, along with impaired FMD and altered cerebral hemodynamics, may serve as markers of endothelial dysfunction and be associated with vascular abnormalities in patients with DKD.
29 January 2026 in The Egyptian Journal of Internal Medicine
Background: Coronavirus disease 2019 (COVID-19) is a global pandemic caused by novel coronavirus SARS-CoV-2. Angiotensin-converting enzyme 2 (ACE2) is a key player in the pathophysiology of COVID-19, as it facilitates the cellular viral entry, which in turn causes upregulation of Angiotensin II (Ang II) which correlates with the severity of infection and inflammation. Objectives: Assessing the serum levels of Ang-II among COVID-19 patients, and correlate it with disease severity. Patients and methods: Eighty patients of COVID- 19 and 80 healthy subjects were enrolled in this cross sectional study. COVID-19 patients was divided to 4 groups; mild, moderate, severe, and critical groups, according to WHO classification of severity of the disease .Beside clinical, laboratory (CBC, CRP, D-dimer, liver and kidney function tests) and imaging assessment, Ang II level was measured using ELISA kits. Results: Levels of Ang-II are significantly higher in COVID-19 patients (281.82 ± 114.54 pg/dl) compared to control (72.53 ± 21.86 pg/dl), with a p-value < 0.001. Significant higher levels were detected in severe and critical cases, which were 347.65 ± 37.70 and 436.06 ± 53.00, respectively, as compared to mild and moderate cases, which were 132.16 ± 27.98 and 216.44 ± 49.47 pg/dl, respectively. An ROC curve for detection of the cutoff value of Ang II level was 115.5 pg/dl with an AUC of 0.990. Moreover, a cutoff value of Ang II for determining the severe and critical cases was 300.05 pg/dl with an AUC of 1.000. Conclusion: Ang-II may be a potential biomarker that could aid in determining the severity of cases aiming at the development of therapeutic strategies to mitigate disease severity.